Boehringer Ingelheim Harnesses GenAI to Transform Case Intake with LifeSphere® NavaX™
Global Biopharma Leader Streamlines Pharmacovigilance with 90% Data Accuracy and Enhanced Efficiency
Seventh Global Life Sciences Company Selects LifeSphere® NavaX™ for GenAI-Driven Case Processing
Top Pharma Taps ArisGlobal for its Advance Intake – a ...
Global Pharma Leader Accelerates AI-Powered Case Processing with LifeSphere® NavaX™
Top 10 Biopharma Streamlines Case Intake with High Data Extraction ...
Sixth Global Pharma Company Selects LifeSphere NavaX for GenAI-Driven Case Processing
Top 25 Global Life Science Organization Adopts NavaX, Demonstrating Industry ...
Lucinda Smith Appointed as Chief Safety Product Officer at ArisGlobal
Boston, Massachusetts, USA – May 15, 2025 – ArisGlobal, an ...
ArisGlobal Introduces Shared Success Model to Guarantee Automation Return on Investment
With the Shared Success Model, ArisGlobal delivers more than just technology — it offers a tested path to operational transformation
ArisGlobal Launches New NavaX Agent – MedDRA Coding Powered by Agentic AI
A Breakthrough in AI-Powered Pharmacovigilance, the Agent will transform MedDRA coding with context-aware, autonomous decision-making.
Global Pharma Organization Implements Advanced Signals as Part of LifeSphere Safety Platform
Another top-tier pharmaceutical company has chosen LifeSphere Advanced Signals.
ArisGlobal announces LifeSphere Unify, NavaX Insights, and Advanced Compliance Docs
At Breakthrough 2025 ArisGlobal unveiled LifeSphere Unify, NavaX Insights, and Advanced Compliance Docs.
Fifth Global Pharma Company Selects LifeSphere NavaX to Drive AI-Powered Case Processing
This marks the fifth leading pharma organization to adopt LifeSphere NavaX, reinforcing the industry’s trust in AI-driven innovation for drug safety and regulatory operations.
